What is Excell Research?
Excell Research operates as a clinical research facility based in Oceanside, California, with a dedicated focus on advancing safe and effective medication therapies, particularly for psychiatric disorders such as depression, anxiety, schizophrenia, OCD, and migraines. Leveraging over 15 years of experience, the company partners with leading pharmaceutical sponsors to conduct clinical trials for innovative treatments. Excell Research provides free study-related care and participant reimbursement, serving patients in Oceanside and surrounding areas, thereby contributing to improved healthcare outcomes through active engagement in clinical research.
How much funding has Excell Research raised?
Excell Research has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Excell Research
PPP
Public-Private Partnership
What's next for Excell Research?
The substantial backing indicated by $150K and the recent strategic investment of $150K suggest Excell Research is in a significant growth phase, likely focusing on expanding its trial capabilities, forging new pharmaceutical partnerships, and potentially broadening its therapeutic areas. This late-stage funding positions the company to further solidify its role in pioneering new treatments for complex psychiatric conditions and enhancing patient access to cutting-edge medical research.
See full Excell Research company page
